Essentials of Biological Security -  - E-Book

Essentials of Biological Security E-Book

0,0
101,99 €

-100%
Sammeln Sie Punkte in unserem Gutscheinprogramm und kaufen Sie E-Books und Hörbücher mit bis zu 100% Rabatt.
Mehr erfahren.
Beschreibung

Essentials of Biological Security A guide to minimizing the threat of misusing benignly intended and dual-use biological research In Essentials of Biological Security: A Global Perspective, a team of distinguished researchers delivers a fundamental resource designed to raise awareness and understanding of biological security as it pertains to the malign manipulation of benignly intended scientific research. Written by experts who have spent decades involved in biological security issues, the book is systematically organized to make it accessible to a wide range of life scientists likely to encounter dangerous opportunities for the deliberate misuse of their research. Readers will also find: * A thorough introduction to biological security and the chemical and biological weapons (CBW) threat spectrum * Comprehensive explorations of the history of biological weapons from antiquity to modern day * Practical discussions of dual-use technologies and how to minimize their risk * Expert analyses of the Biological and Toxin Weapons Convention and other relevant international agreements and organizations Perfect for professionals working in life sciences, medicine, global health, biosafety, and biosecurity, Essentials of Biological Security: A Global Perspective will also benefit anyone with an interest in and being responsible for biological security.

Sie lesen das E-Book in den Legimi-Apps auf:

Android
iOS
von Legimi
zertifizierten E-Readern

Seitenzahl: 653

Veröffentlichungsjahr: 2024

Bewertungen
0,0
0
0
0
0
0
Mehr Informationen
Mehr Informationen
Legimi prüft nicht, ob Rezensionen von Nutzern stammen, die den betreffenden Titel tatsächlich gekauft oder gelesen/gehört haben. Wir entfernen aber gefälschte Rezensionen.



Table of Contents

Cover

Table of Contents

Title Page

Copyright Page

Endorsement

List of Figures

List of Tables

List of Contributors

Foreword

Acknowledgements

Acronyms

1 Biological Security After the Pandemic

1.1 The Objective of the Book

1.2 The Structure of the Book

1.3 Overview of the Chapters

Author Biography

References

2 Falling Between the Cracks and by the Sides: Can Disarmament Treaties Respond to Scientific and Technological Developments?

2.1 Introduction

2.2 Concepts of Disease and Toxicants in Relationship to CBW

2.3 Capturing Evolving Concepts of Disease and Toxicants in Restraining Warfare

2.4 Further Development of the Control of Toxic Weapons

2.5 Implications of Evolving Concepts and S&T Developments for Disarmament Law

2.6 Conclusions: Responding to S&T Developments

Author Biography

References

3 A Multifaceted Threat

3.1 Introduction

3.2 Assessing the Utility and Scope of Biological Weapons at Various Scales

3.3 Diverse Objectives of Bioweapon Use: Past and Present

3.4 Evolving Biotechnologies

3.5 Changing Biothreat Landscapes

3.6 Conclusion

Author Biography

References

4 Biological Weapons from the Ancient World to 1945

4.1 Introduction

4.2 Map of the Literature

4.3 Historical Review

4.4 Conclusions

Author Biography

References

5 Biological Weapons from 1946 to 2000

5.1 Introduction

5.2 Overview of State BW Programmes

5.3 Offensive Aspects of BW Programmes

5.4 Non‐state Actors

5.5 Drivers and Inhibitors of State BW Programmes

5.6 Conclusions

Author Biography

References

6 The Problem of Dual Use in the Twenty‐first Century

6.1 Relationship of the Advances in Science and Technology to the BTWC

6.2 Evolution of the Dual‐Use Dilemma

6.3 DURC Criteria with Examples in Each Case of Published Research Reports of Work That Has DURC Character

6.4 Problems in Dealing with Dual Use: Debates About What Should Be Done

Author Biography

References

7 Key Cutting‐Edge Biotechnologies Today

7.1 Introduction

7.2 Development and Application of Synthetic Biology

7.3 Development and Application of Genome Editing

7.4 Main Biosafety and Biosecurity Concerns Associated with Key Cutting‐Edge Biotechnologies

7.5 Conclusions

Author Biography

References

8 Convergence of Science and Technology

8.1 Introduction

8.2 Convergence of Science and Technology in the Life Sciences

8.3 Convergence and Arms Control and Security

8.4 Technologies of Particular Relevance for Possible Misuse of Biology for Nefarious Purposes

8.5 Mitigation of the Evolving Misuse Potential Resulting from Convergence

Author Biography

References

9 Role of the Life Science Community in Strengthening the Web of Prevention for Biosafety and Biosecurity

9.1 Introduction

9.2 Integrating Biosafety with Biosecurity: The Web of Prevention as a Model Concept

9.3 Addressing the Threat of Deliberate Biological Events and Life Science Misuse

9.4 Implications for the Governance of Biotechnology in the Twenty‐first Century

Author Biography

References

10 The 1925 Geneva Protocol and the BTWC

10.1 Introduction

10.2 The Origins and Evolution of the 1925 Geneva Protocol and the BTWC

10.3 The Review Conferences of the BTWC and Their Outcomes: 1980–2022

10.4 Biological Disarmament as It Is: Strengths and Weakness of the BTWC and the Geneva Protocol in the Twenty‐first Century

10.5 The BTWC Beyond 50 and the Geneva Protocol Beyond 100: Can They Prevent Biological Warfare?

10.6 Conclusion

Author Biography

References

11 Constraining the Weaponisation of Pathogens and Toxic Chemicals Through International Human Rights Law and International Humanitarian Law

11.1 Introduction

11.2 International Humanitarian Law

11.3 International Human Rights Law

11.4 Conclusions

Author Biography

References

12 The Role of International Organisations in Biosecurity and the Prevention of Biological Warfare

12.1 Introduction

12.2 The Role of IOs in Fostering the Norm Against Biological Weapons

12.3 IOs in the Genesis of the Biological and Toxin Weapons Convention

12.4 IOs and the Evolution of Biosecurity Governance

12.5 The Strengths of IOs in Biosecurity and Prevention of Biological Warfare

12.6 The Limits of IOs in Biosecurity and Prevention of Biological Warfare

12.7 Conclusions

Author Biography

References

13 Laboratory Biorisk Management as a Key Tool for Scientists to Understand Future Biological Threats and Strengthen the Biological Weapons Convention

13.1 History, Context and Current International Guidance

13.2 Biosafety and Biosecurity Awareness

13.3 The Role of Scientists: Tailored Biorisk Management Practices

13.4 Case Scenarios: Practical Examples

13.5 An Ongoing Cycle to Strengthen the Biological Weapons Convention

Author Biography

References

14 Examples of Biorisk Management National Regulatory Frameworks

14.1 Introduction

14.2 Laboratory Biosafety and Biosecurity in the US

14.3 Import–Export and Transportation of Infectious Substances in the US

14.4 Genetic Engineering and Dual‐Use Oversight in the US

14.5 The Culture of Biosafety, Biosecurity and Responsible Conduct in the US

14.6 The Biorisk Management National Regulatory Framework of Georgia

14.7 Conclusion

Author Biography

References

15 Lessons from ePPP Research and the COVID‐19 Pandemic

15.1 Advances in Life Science and Technology and the Emergence of ‘So‐Called GOF Studies’ to Create ePPPs

15.2 Controversy Surrounding GOF Studies on H5N1 Highly Pathogenic Avian Influenza Virus

15.3 COVID‐19 and GOF Studies on SARS‐like Viruses

15.4 Ongoing Discussions at the NSABB and Governance by HHS

15.5 Future Governance of GOF Research and Prospects

Author Biography

References

16 The Hague Ethical Guidelines and the Tianjin Biosecurity Guidelines

16.1 Relations Between the Hague Ethical Guidelines and the Tianjin Biosecurity Guidelines

16.2 BTWC Advances the Formulation of the Tianjin Biosecurity Guidelines for Responsible Scientific Research

16.3 Constitution of the Tianjin Biosecurity Guidelines: Ideas, Principles, Elements and Path Formation

16.4 Future Discussion

Author Biography

References

17 Engaging Scientists in Biorisk Management

17.1 Introduction: Scientists Engagement and Biorisk Management

17.2 Engaging Scientists in Biorisk Management at International Level: Case from IWG Assessment Framework

17.3 Engaging Scientists in Biorisk Management in National Institutional Oversight: Case from the Netherlands

17.4 Engaging Scientists in Biorisk Management in Community: Case from iGEM

17.5 Conclusion: How to Engage Scientists in Management of Biorisk and Other Emerging Fields

Author Biography

References

18 The Role of Ethics in Dealing with Dual Use

18.1 The Dual‐Use Concept and Concerns

18.2 Ethics as an Instrument on Dual‐Use Governance

18.3 Existing and Complementary Ethical Guidelines on Dual Use

18.4 Recent Dual‐Use Scenarios

18.5 Ethical Education for Future Dual Use

Author Biography

References

19 Where Is the Governance of Dual‐Use Science Going?

19.1 Background: Genetic Technologies and Their Applications

19.2 Dual‐Use Science: Evolving Story of a Dualistic Term

19.3 Begin with the Experts: Models of Self‐regulation

19.4 Alternative Governance Structures

19.5 Conclusion

Author Biography

References

20 Towards an International Biosecurity Education Network (IBSEN)

20.1 Introduction

20.2 The Need for Biosecurity Education, Awareness‐Raising and a Culture of Responsibility in the Life Sciences

20.3 Past Efforts in Educating Life Scientists and Establishing a Culture of Responsibility

20.4 Challenges Faced by Biosecurity Education and Awareness‐Raising

20.5 Comparable Approaches Implemented in Analogous Frameworks in the Nuclear and Chemistry Fields

20.6 Conclusion

Author Biography

References

Appendix A: The Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists

**

Index

End User License Agreement

List of Tables

Chapter 1

Table 1.1 Topics and numbers of biosecurity questions.

Table 1.2 Priority DURC issues identified in the five‐year timescale.

Table 1.3 Stakeholders identified by the WHO.

Table 1.4 Some recommendations made by the NSABB.

Table 1.5 The sections of the book.

Chapter 6

Table 6.1 Criteria for the identification of DURC along with an example of ...

Chapter 9

Table 9.1 Overview of the Joint External Evaluations (JEE) Tool.

Chapter 15

Table 15.1 Criteria for guiding HHS funding decisions for certain H5N1 gain...

Chapter 17

Table 17.1 The 15 themes of Dual‐Use Quickscan.

Chapter 18

Table 18.1 Main principles on bioethics.

Chapter 20

Table 20.1 Selection of education and awareness‐raising initiatives for lif...

List of Illustrations

Chapter 2

Figure 2.1 Development of international law banning poison weapons.

Chapter 8

Figure 8.1 Relative ranking of concerns related to synthetic biology‐enabled...

Chapter 9

Figure 9.1 Biological threat spectrum.

Figure 9.2 WOAH organisational and operational guidelines for investigation ...

Figure 9.3 Indicative legal frameworks applicable to the biological crime li...

Chapter 20

Figure 20.1 Example of biosecurity education graphic novel produced by the U...

Guide

Cover Page

Table of Contents

Title Page

Copyright Page

Endorsement

List of Figures

List of Tables

List of Contributors

Foreword

Acknowledgements

Acronyms

Begin Reading

Index

WILEY END USER LICENSE AGREEMENT

Pages

iii

iv

xv

xvi

xvii

xviii

xix

xx

xxi

xxii

xxiii

xxv

xxvii

xxviii

xxix

xxx

xxxi

xxxii

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

31

32

33

34

35

36

37

38

39

40

41

43

44

45

46

47

48

49

50

51

52

53

54

55

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

83

84

85

86

87

88

89

90

91

92

93

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

161

162

163

164

165

166

167

168

169

170

171

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

237

238

239

240

241

242

243

244

245

246

247

248

249

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

Essentials of Biological Security

A Global Perspective

Edited by

Lijun Shang

Biological Security Research CentreSchool of Human SciencesLondon Metropolitan UniversityLondon, UK

Weiwen Zhang

Center for Biosafety Research and StrategyTianjin UniversityTianjin, China

Malcolm Dando

School of Social SciencesUniversity of BradfordBradford, UK

This edition first published 2024© 2024 John Wiley & Sons Ltd

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.

The right of Lijun Shang, Weiwen Zhang, and Malcolm Dando to be identified as the editorial material in this work has been asserted in accordance with law.

Registered Office(s)John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USAJohn Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK

For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.

Wiley also publishes its books in a variety of electronic formats and by print‐on‐demand. Some content that appears in standard print versions of this book may not be available in other formats.

Trademarks: Wiley and the Wiley logo are trademarks or registered trademarks of John Wiley & Sons, Inc. and/or its affiliates in the United States and other countries and may not be used without written permission. All other trademarks are the property of their respective owners. John Wiley & Sons, Inc. is not associated with any product or vendor mentioned in this book.

Limit of Liability/Disclaimer of WarrantyWhile the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.

Library of Congress Cataloging‐in‐Publication Data

Names: Shang, Lijun, editor. | Zhang, Weiwen (Professor of microbiology and biochemical engineering), editor. | Dando, Malcolm, editor.Title: Essentials of biological security : a global perspective / edited by Lijun Shang, Weiwen Zhang, Malcolm Dando.Description: Hoboken, NJ : Wiley, 2024. | Includes index.Identifiers: LCCN 2023053440 (print) | LCCN 2023053441 (ebook) | ISBN 9781394189014 (cloth) | ISBN 9781394189021 (adobe pdf) | ISBN 9781394189038 (epub)Subjects: LCSH: Biosecurity.Classification: LCC JZ5865.B56 E88 2024 (print) | LCC JZ5865.B56 (ebook) | DDC 363.325/3–dc23/eng/20231201LC record available at https://lccn.loc.gov/2023053440LC ebook record available at https://lccn.loc.gov/2023053441

Cover Design: WileyCover Image: © Image Source/Getty Images

Endorsement

Impressive dedication displayed by prominent experts, led by Lijun Shang, Weiwen Zhang and Malcolm Dando, has culminated in the creation of this remarkable book, a testament to their commitment. It delves into the pressing issue of biosecurity with a specific focus on preventing intentional disease outbreaks in humans, animals, and plants. It underscores the intricate connections between natural, accidental, and deliberate disease prevention, with a particular emphasis on preventing acts of malevolence.

The realm of biosecurity is extensive, extending far beyond the boundaries of life sciences and the Biological and Toxin Weapons Convention. This publication is in harmony with the WHO's Global Framework, placing significant emphasis on the collaborative role of various stakeholders in bolstering the management of biohazards and focusing on the crucial areas of biosecurity education and code of conduct.

The book comprehensively covers the threat posed by biosecurity concerns, the international responses to these challenges, the pivotal role played by scientists and the prospective future of biosecurity. Notably, it underscores the pressing need for the establishment of an International Biosecurity Education Network and the responsible engagement of scientists.

Prof. Aamer Ikram, HI(M)

Ex‐CEO National Institute of Health PakistanChair Board International Federation of Biosafety AssociationsChair Advisory Board TEPHINETMember Executive Board IANPHI, Gavi; The Vaccine Alliance, ISTR

The global biosecurity situation has become increasingly severe in recent years due to emerging threats from natural epidemic outbreaks, the misuse and abuse of biotechnology and bioterrorism, among others. Biosecurity has become an important part of overall national security in many nations. Such challenges highlight the needs to reform the existing biosecurity education system. I am thus very delighted to see the book by a group of world‐prominent experts led by Profs. Lijun Shang, Weiwen Zhang and Malcolm Dando specifically address the needs and create an updated biosecurity resource book that could easily be utilised by practicing life scientists in an educational programme. Under the framework of the Tianjin Biosecurity Guidelines of the UN Biological Weapon Convention, the book presents an excellent overview of the entire landscape of key fundamentals essential for biological security education for future life scientists. The broad topics covered by the book include most of the issues related to biosafety and biosecurity and therefore will attract experts and students, which will eventually help build suitable biosecurity education systems across the world.

Prof. Ying‐Jin Yuan

Professor of Synthetic BiologyAcademician of Chinese Academy of SciencesTianjin University, P.R. China

The new book edited by Prof. Lijun Shang, Dr. Weiwen Zhang and Em. Prof. Malcolm Dando on different aspects of biological security will drive the readers on a journey that goes from framing the problem by first understanding the past events in the biological weapons arena; to then putting in context the current threats and possible responses and, finally, thinking of future scenarios, particularly in the current fast‐evolving scientific and technological world.

Following the logic presented in the WHO Global framework, when it comes to the importance of understanding the roles and needs of different actors, the book includes chapters from experts from different countries, representing universities, international organisations, NGOs and government and private companies, collecting, in this way, the opinions of the major biological security stakeholders and, consequently, building a broad and multidisciplinary perspective on biorisks management.

One of the outstanding conclusions is the importance of increasing education on biosecurity and biorisks management as a way to improve biological security in a sustainable way.

Dr. Maria Espona

ArgIQ codirector, professor at UCA, Catholic University Argentina

List of Figures

Figure 2.1

Development of international law banning poison weapons

Figure 8.1

Relative ranking of concerns related to synthetic biology‐enabledcapabilities, according to US National Academies of Sciences, Engineering, Medicine (2018)/National Academies Press

Figure 9.1

Biological threat spectrum

Figure 9.2

WOAH organisational and operational guidelines for investigation of suspicious biological events

Figure 9.3

Indicative legal frameworks applicable to the biological crime lifecycle

Figure 20.1

Example of biosecurity education graphic novel produced by the US Bipartisan Commission on Biodefense (2019)

List of Tables

Table 1.1

Topics and numbers of biosecurity questions

Table 1.2

Priority DURC issues identified in the five‐year timescale

Table 1.3

Stakeholders identified by the WHO

Table 1.4

Some recommendations made by the NSABB

Table 1.5

The sections of the book

Table 6.1

Criteria for the identification of DURC along with an example of work published in scientific Journals that illustrate each type

Table 9.1

Overview of the Joint External Evaluations (JEE) Tool

Table 15.1

Criteria for guiding HHS funding decisions for certain H5N1 gain‐of‐function research proposals

Table 17.1

The 15 themes of Dual‐Use Quickscan

Table 18.1

Main principles on bioethics

Table 20.1

Selection of education and awareness‐raising initiatives for life scientists

List of Contributors

Mayra AmeneirosCentre for Science and Security StudiesKing's College LondonLondon, UK

Lela BakanidzeEU CBRN Centers of Excellence RegionalSecretariat for Central AsiaTashkent, Uzbekistan

Brian BalmerDepartment of Science andTechnology StudiesUniversity College LondonLondon, UK

Yuhan BaoiGEM FoundationCambridge, MA, USAandTsinghua University, Beijing, China

Gemma BowsherSchool of Security StudiesKing’s College LondonLondon, UK

Nancy ConnellRutgers New Jersey Medical SchoolNewark, NJ, USA

Michael CrowleyBradford UniversityBradford, UK

Malcolm DandoSchool of Social SciencesUniversity of BradfordBradford, UK

Brett EdwardsDepartment of Politics, Languagesand International StudiesUniversity of BathBath, UK

Alonso FloresiGEM Foundation, CambridgeMA, USA

Gigi GronvallCenter for Health SecurityJohns Hopkins University BloombergSchool of Public HealthBaltimore, MD, USA

Jaroslav KrasnyWeapons of Mass DestructionProgramme, UNIDIRGeneva, Switzerland

Jez LittlewoodIndependent Consultant, EdmontonAB, Canada

Louison MazeaudWeapons of Mass DestructionProgramme, UNIDIRGeneva, Switzerland

Kathryn MillettBiosecure LtdCheltenham, UK

Kathryn NixdorffDepartment of Microbiology and GeneticsTechnical University of DarmstadtDarmstadt, Germany

Tatyana NovossiolovaLaw Program‐Center for the Studyof DemocracySofia, Bulgaria

Dana PerkinsFormer member of the Group of Expertssupporting the United Nations SecurityCouncil 1540 Committee on Weapons ofMass Destruction Non‐ProliferationNew York, NY, USA

James RevillWeapons of Mass Destruction Programmeand Space Security Programmes, UNIDIRGeneva, Switzerland

Lijun ShangBiological Security Research Centre,School of Human SciencesLondon Metropolitan UniversityLondon, UK

Nariyoshi ShinomiyaNational Defense Medical CollegeTokorozawa, Japan

Xinyu SongCenter for Biosafety Research and StrategyTianjin UniversityTianjin, China

Ralf TrappIndependent ConsultantChessenaz, France

Leifan WangCenter for Biosafety Research and StrategyTianjin University Law SchoolTianjin, China

Yang XueCenter for Biosafety Research and StrategyTianjin UniversityTianjin, China

Jean Pascal ZandersIndependent disarmament researcher atThe Trench

Weiwen ZhangCenter for Biosafety Research and StrategyTianjin UniversityTianjin, China

Vivienne ZhangWeapons of Mass Destruction Programmeand Space Security Programmes, UNIDIRGeneva, Switzerland

Foreword

Studying biosecurity after the great COVID‐19 pandemic has two different levels of importance. The first is a relative value, represented by the dynamics of the pandemic crisis itself. It has affected the entire world’s society in a historically novel framework because it is marked by disruptive advances in the life sciences. This scientific aspect is apparently secondary to the growth of the world's population and the consequent mobility of large masses of people, which, together with the concentration of even larger masses of people, has outlined an unprecedented scenario for the viral spread and thus for the pandemic. Indeed, the growth of the world's population has also been made possible by advances in the life sciences and access to medicines for ever‐larger sectors of the world's population. An advance in applied knowledge has allowed a technological shift in some biomedical research laboratories, transforming them from low‐security sites into fully fledged critical infrastructures. The effects of a security/safety breach can now go far beyond the loss of materials and equipment and constitute a serious risk whose extent is still being defined. The very solutions offered to the pandemic crisis can be placed within this framework of advancement in the life sciences, in particular for mRNA vaccines, but also for virus detection. Possible technical solutions are intertwined with possible safety solutions in their application, shaping the options on which political decisions have been exercised.

The second value of biosecurity studies is an absolute one, which invests in institution‐building and the work of the institutions themselves, starting with research institutions and moving on to international institutions via national ones. Working on biosafety means embracing a range of issues that affect the economy and society, as well as the policymaking that drives both. But it also means interacting with other applied research and security paradigms such as cybersecurity and in some cases radionuclear security. Therefore, biosecurity research must and can, as the chapters in this book testify, bring security applied to other technologies under a new approach. This leads us to reflect on the specifics of biosecurity in relation to the other securities that make up CBRN+Cy (Chemical, Biological, Radiological and Nuclear plus Cyber). If we think about the possibility of controlling and tracking the material, biosecurity is at the other end of the controllability scale compared to nuclear security. While nuclear material is undoubtedly the most controlled and controllable for mankind, the materials that biosecurity has to control are the most uncontrollable. This material fact has implications for security institutions and their activities.

Material difficulty, even before the secrecy of information, has informed the development and spread of nuclear technology. A material difficulty that was and is composed of various elements, such as the costs of nuclear fuel cycle management, nuclear material procurement and reprocessing equipment. The difficult technical and economic viability constituted a first line of 'passive' limitation to the uncontrolled spread of nuclear materials, effectively restricting the possibilities of the use of nuclear technology by another State other than the ‘club’ of nuclear powers. This point, which is politically fundamental, is useful in comparative terms with respect to the biological. For the first period in the history of nuclear weapons, the US monopoly subsumed control of nuclear materials, which continued after the Soviet test in a shared and normed control. Added to the impossibility for the majority of States in the international community to bear the costs of uranium enrichment was the model of international cooperation agreement that the US offered after the launch of the ‘Atoms for Peace’ programme. An agreement that conditioned the transfer of materials and technology on the US verifying their use by the receiving state. This model was gradually extended to other nuclear technology and materials providers through the technical role assigned to the IAEA.

On these assumptions, the safeguards system was built, which from the point of view of international instruments differed profoundly from an arms prohibition agreement. Indeed, it was not through prohibition that the superpowers exercised control over the spread of nuclear weapons, but through cooperation and the promotion of nuclear technology itself. Hypothetically, cooperation could provide the means for a nuclear weapons programme, but instead it implemented the exact opposite, subjecting the recipient state to controls that prevented the realisation of a weapons programme. This form of control implied the distinction between dual‐use and non‐dual‐use technologies and materials and equally implied the creation of institutions to control dual‐use. Why this choice of controlled openness instead of maintaining the previous closure and secrecy? By the end of the 1950s, the US leadership had realised that the secrecy of information and the cost and technical difficulties of enriching uranium and separating plutonium could not forever prevent many States from acquiring nuclear weapons. It was in some respects what Thomas P. Hughes called ‘technological momentum’. With ‘Atoms for Peace’, a phase of building a technodiplomatic system was opened that led up to the Nuclear Non‐Proliferation Treaty (NPT), which remains in force to this day. The creation of this system was made possible by a substantial convergence between the superpowers, a détente that benefited the entire international system.

On the other hand, along with the control of weapons programmes, the only other problem that affected the community of States when the NPT came into force was that of the safety of nuclear facilities, hence of the personnel working in them, and subsequently of the environment. Safety covered the possibilities of accidents or unintentional mishandling of nuclear materials and radiological sources. There was therefore no question of malicious use, hence security. Everything was attributable to State action, and therefore non‐State actors such as criminals and terrorist organisations could only make malicious use of nuclear materials and radiological sources in James Bond films. But the continuation of the aforementioned technological dynamic led not only to a vast number of States being able to approach a nuclear weapons programme, but also to non‐State actors appropriating nuclear materials and technology. The nuclear black market obviously saw other States as its first customers, but it was conducted by criminal organisations. This made it possible not only for North Korea to have a nuclear weapons programme but also for the risk of nuclear terrorism.

Thus, a distinction had to be made between safety and security, in languages where this distinction is possible. Obviously, the linguistic distinction followed a conceptual distinction, which developed a consequent institutional creation in the IAEA system. This distinction does not develop in parallel because security is an additional element of safety. If a plant is not safe, it will also inevitably have a security risk. If a plant is only safe, it cannot respond to a security risk. So, safety is a necessary condition for developing security. What has been said may logically seem a banality, but it is precisely on the common factors of safeguards, safety and security that the three ‘S’ approach has been promoted in Japan, which rationalises costs and optimises systems. An optimisation that, it must be said, is by no means the majority both at the level of States and in international organisations, for different reasons between the two plans (national and international). In fact, security belongs primarily to States, while safeguards and part of safety belong to international organisations, mainly the IAEA.

This summary of things that are already known may seem too long and distracting, but these are considerations arising from the coherent structure of the chapters in this book and from the intentions stated by the editors. Precisely because the biological is as far removed from the radionuclear, it is possible and necessary to organise the three ‘S’s differently. In the half century from the Geneva Protocol of 1925 to the Biological and Toxin Weapons Convention of 1975, it has not been possible to establish a control regime similar to that of nuclear safeguards. Following the Convention, however, it was possible to establish a system of confidence‐building measures, which is similar to what the IAEA is promoting in nuclear security. Or, if one looks at safety, it is immediately apparent from reading the chapters of the book how much more intertwined it is with security than in the nuclear realm. There is a natural tendency, due to the very materiality of the biological, to move without hiatus from the interdiction of bacteriological and toxin weapons to biosafety and biosecurity, as the book makes clear.

Hence, biosecurity, rather than being an additional element of safety, conforms to a possible synthesis between safety and confidence‐building measures, suited to the current international risk scenario. The value of the book, however, is not only contained in the quality of the individual chapters but also in the technopolitical proposal to create an international network for education in biosecurity, with the dramaturgical acronym IBSEN. Experience would be all in favour of such an attempt, promoted by the WHO just as the IAEA has promoted the international network for nuclear security education. With the significant difference of being able to develop and promote transnational education programmes in a booming technoscientific field. And in a field in which biosecurity must not be limited by a strict separation from safety, which is bureaucratic before being conceptual, as is the case with nuclear power. As Harvard's Belfer Center also reports, the life sciences are fundamental to driving scientific progress, benefiting everything from public health to agriculture and environmental preservation. Yet, it is vital to recognise and mitigate potential risks, especially in the realms of biosafety and biosecurity. Training and education are needed to do this because the critical element in safety/security in life sciences is the human element, much more so than in other CBRN. Anyone wishing to develop an education programme in biosecurity will find in the following pages not only insightful researches but also a relevant contribution to many courses of study.

Professor Matteo Gerlini

Chair of the International Nuclear Security Education Network (INSEN)University of Siena, Department of Political and International SciencesSienaItaly

Acknowledgements

We would like to thank all of the authors for submitting their chapter outlines, drafts and final versions according to the very tight agreed timetable, and some of the authors for engaging with us in discussions of their chapters. The chapter authors, nevertheless, have sole responsibility for their own chapters. We would also like to thank the members of the Tianjin University Faculty who kindly assisted us in checking the format of all of the chapters and references.

The Editors

Acronyms

A

ABEO

Advisory Board for Education and Outreach (of OPCW/SAB)

ACE2

Human receptor type

Ag‐RDTs

Antigen detecting rapid diagnostic tests

AI

Artificial intelligence

AM

Additive manufacturing

APHIS

Animal and Plant Health Inspection Service (USA)

APP3

Action Package Prevent‐3, Biosafety and Biosecurity (of the GHSA)

ASAP

Artificial starch anabolic pathway

ASPR

Administration for Strategic Preparedness and Response (USA)

B

BACAC

Biosafety Association for Central Asia and Caucasus

BMBL

Biosafety in Microbiological and Biomedical Laboratories (Guidance)

BSAT

Biological select agents and toxins

BSE

Bovine spongiform encephalitis

BSL

Biosafety level

BTRP

Biological Threat Reduction Program

BTWC

Biological and Toxin Weapons Convention

BW

Biological weapon

BWC

Biological Weapons Convention (short form of BTWC)

C

CAR T

Cell therapy

CAT

Chloramphenicol acetyl transferase (Enzyme)

CB

Chemical and biological

CBP

Customs and Border Protection (USA)

CBRN

Chemical, biological, radiological and nuclear

CBRS

Center for Biosafety Research and Strategy (Tianjin University)

CBW

Chemical and biological weapons

CCD

Conference of the Committee on Disarmament

CD

Conference of Disarmament

CDC

Centers for Disease Control and Prevention (USA)

CIA

Central Intelligence Agency (USA)

CIDTP

Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment

CND

Campaign for nuclear disarmament

CO

2

Carbon dioxide

CoE

Centres of Excellence (EU CBRN Risk Mitigation)

COVID‐19

COVID‐19 pandemic (virus)

Cpf1

CRISPR effector

CPT

Committee for the Prevention of Torture

CRISPR/Cas

Genome editing technique

CTBT

Comprehensive Test Ban Treaty

CTR

Cooperative threat reduction

CW

Chemical weapon

CWC

Chemical Weapons Convention

CWS

Chemical Warfare Service (USA)

D

3D

Three dimensional (protein folding)

DHB

District Health Board (Waikato, New Zealand)

DNA

Deoxyribonucleic acid

DOD

Department of Defense (USA)

DTRA

Defense Threat Reduction Agency (USA)

DURC

Dual Use Research of Concern

E

E&O

Education and outreach

EAR

Export Administration Regulations (USA)

EDP

Extremely dangerous pathogens

EEAS

European External Action Service

ELBI

Emerging Leaders in Biosecurity Fellowship

ENMOD

Convention on the Prohibition of Military or Any Other Hostile Use of Environmental Modification Techniques

ENDC

Eighteen Nation Disarmament Committee

ePPPs

Enhanced potential pandemic pathogens

EU

European Union

EU CBRN CoE

EU CBRN Risk Mitigation Centres of Excellence Initiative

EWARS

Early Warning, Alert, and Response System (of the WHO)

F

FAO

Food and Agriculture Organization

FBI

Federal Bureau of Investigation

FDA

Food and Drug Administration (USA)

FESAP

Federal Experts Security Advisory Panel (USA)

FIRES

Documentary Video Project (OPCW)

FSAP

Federal Select Agent Program (USA)

G

GASR7

Gene

GeBSA

Georgian Biosafety Association

GHSA

Global Health Security Agenda

GHSI

Global Health Security Initiative

GMO

Genetically Modified Organism

GOARN

Global Outbreak Alert and Response Network

GOF

Gain‐of‐Function (experiment)

GPC

General purpose criterion

gRNA

Guide ribonucleic acid

H

H1N1

Novel influenza virus

H5N1

Avian influenza virus

H7N5

Avian influenza virus

HIV

Human immunodeficiency virus

HHS

Department of Health and Human Services (USA)

I

IAEA

International Atomic Energy Agency

IAP

InterAcademy Panel

IAP

International Association of Prosecutors

IBSEN

International Biosecurity Security Education Network

ICCA

International Council of Chemical Associations

ICCPR

International Covenant on Civil and Political Rights

ICPO‐INTERPOL

International Criminal Police Organization

ICRC

International Committee of the Red Cross

ICST

International Collaborations in Science and Technology

ICT

Information computer technology

ICTA

International Chemical Trade Association

IFBA

International Federation of Biosafety Associations

iGEM

International Genetic Engineering Machine Competition

IHL

International Humanitarian Law

IHR

International Health Regulations

IHRL

International Human Rights Law

IL‐4

Interleukin‐4

INB

International Network on Biotechnology

INSEN

International Nuclear Security Education Network

INTERPOL

International Criminal Police Organization

IO

International Organisation

IRB

Institutional Review Board

ISO

International Organisation for Standardisation

ISTC

International Science and Technology Center

ISU

Implementation Support Unit (of the BTWC)

ITA

International Traffic in Arms Regulations (USA)

INTERPOL

International Criminal Police Organisation

IUPAC

International Union of Pure and Applied Chemistry

IWG

International Working Group

J

JEE

Joint External Evaluation Tool (of the IHR)

L

LMO

Living modified organisms

M

MERS

Virus

MIT

Massachusetts Institute of Technology

ML

Machine learning

MMUST

Masinde Muliro University of Science and Technology (Kenya)

MoJ

Ministry of Justice (Georgia)

mRNA

Messenger ribonucleic acid

MSP

Meeting of States Parties (BTWC)

MX

Meeting of Experts (BTWC)

MYBPC3

Gene

N

NASEM

National Academies of Science, Engineering and Medicine (USA)

NCDC

National Center for Disease Control and Public Health (Georgia)

NGO

Non‐government organisation

NPT

Nuclear Non‐Proliferation Treaty

NRC

National Research Council (USA)

NSABB

National Science Advisory Board for Biosecurity (USA)

NSC

White House National Security Council (USA)

NUSEC

Nuclear Security Information Portal

O

OPCW

Organisation for the Prohibition of Chemical Weapons

OSH Act

Occupational Safety and Health Act (USA)

OSHA

Occupational Health and Safety Administration (USA)

OSTP

White House Office of Science and Technology Policy (USA)

P

P3CO

Potential Pandemic Pathogen Care and Oversight (USA)

PAM

Protospacer adjacent motif

PDCA

Plan–do–check–act (cycle)

POC

Point of care

PPE

Personal protective equipment

R

R&D

Research and development

RCAs

Riot control agents

RISE

Group of American teenage criminals

S

S&T

Science and technology

SAB

Scientific Advisory Board (of the OPCW)

SARS

Virus

SARS‐CoV‐2

Virus

SEB

Staphylococcal enterotoxin B

SGTEB

Sous Groupe de Travail et d’Etudes Biologiques

SIRUS

Superfluous injury or unnecessary suffering (prohibition)

STCU

Science and Technology Center in Ukraine

T

TALENs

Traditional genome editing tools

TCR

Genetically engineered T cells

TJU‐CBRS

Tianjin University Center for Biosafety Research and Strategy

TPNW

Treaty on the Prohibition of Nuclear Weapons

U

UK

United Kingdom of Great Britain and Northern Ireland

UN

United Nations

UNBP

UN Basic Principles on the Use of Force and Firearms by Law Enforcement Officials

UNCoC

UN Code of Conduct for Law Enforcement Officials

UNEP

United Nations Environment Program

UNESCO

United Nations Educational, Scientific and Cultural Organization

UNICRI

United Nations Interregional Crime and Justice Research Institute

UNIDIR

United Nations Institute for Disarmament Research

UNODA

United Nations Office of Disarmament Affairs

UNSC

United Nations Security Council

UNSCR 1540

United Nations Security Council 1540

UNSGM

United Nations Secretary General’s Mechanism

US$

United States dollars

US(A)

United States of America

USDA

US Department of Agriculture

USG

US Government

USSR

Union of Soviet Socialist Republics

V

VEREX

Verification Experts Group (of the BTWC)

VX

Nerve agent

W

WAHIS

World Animal Health Information System

WHO

World Health Organization

WILPF

Women’s International League for Peace and Freedom

WINSI

Women in Nuclear Security Initiative

WMD

Weapons of Mass Destruction

WOAH

World Organisation for Animal Health

WWI

World War One

WWII

World War Two

Z

ZFNs

Traditional genome editing tools

1Biological Security After the Pandemic

Lijun Shang1, Weiwen Zhang2, and Malcolm Dando3

1 Biological Security Research Centre, School of Human Sciences, London Metropolitan University, London, UK

2 Center for Biosafety Research and Strategy, Tianjin University, Tianjin, China

3 School of Social Sciences, University of Bradford, Bradford, UK

Key Points

Biosecurity concerns the prevention of natural, accidental and deliberate disease in humans, animals and plants. All three aspects of preventing natural, accidental and deliberate disease are interrelated and improvements in each can support the others, but the focus here is on preventing deliberate disease.

While the focus is on the life sciences and the Biological and Toxin Weapons Convention (BTWC), we take a broad view of the threat and the regulatory regime, particularly to include mid‐spectrum agents such as toxins and bioregulators and the Chemical Weapons Convention (CWC).

We follow the World Health Organisation's Global Framework in seeing multiple stakeholders having a range of tools and mechanisms that can be used to improve biorisk management. The focus here is on the need for biosecurity education, particularly for life and associated scientists in support of the Tianjin Guidelines.

The book is divided into 20 chapters in five sections: Introduction and Overview (1 chapter); The Threat (7 chapters); The International Response (4 chapters); The Role of Scientists (6 chapters); and The Future (2 chapters).

In the longer term, we see the need for an International Biosecurity Education Network (IBSEN) similar to the International Nuclear Security Education Network (INSEN) run by the International Atomic Energy Agency (IAEA).

Summary

The chapter begins by stressing the importance of improving biosecurity after the pandemic and defines biosecurity as the prevention of natural, accidental and deliberate disease in humans, animals and plants. While stressing the all three aspects are interrelated and critical to each other, the chapter makes it clear that the focus of this book is on the prevention of deliberate disease. Moreover, while the focus is on the life sciences and the BTWC, a broad view is taken of the threat and the regulatory regime so as to include mid‐spectrum agents such as toxins and bioregulators and particularly the CWC. It is argued that the WHO Global Framework is the best approach to biosecurity, with multiple stakeholders being seen as having a range of tools and mechanisms available to help improve biorisk management and that the essential component that is of concern here is biosecurity education in support of the Tianjin Guidelines. The sections and chapters of the book are then outlined before it is suggested that in the longer term an International Biosecurity Education Network (IBSEN) similar to The International Nuclear Security Education Network (INSEN) run by the IAEA will be needed to effectively improve biosecurity.

1.1 The Objective of the Book

In 2019, a large group of government and non‐government experts were drawn together in an exercise to produce a list of critical questions for future biosecurity in the United Kingdom. The exercise had been organised by the Biosecurity Research Initiative at St. Catherine's College, University of Cambridge, and consisted of a three‐phase process in which firstly a panel identified 59 experts from a range of disciplines, then secondly these experts were asked to draw on their own contacts to propose lists of tractable but unanswered biosecurity questions and finally a subset of 32 experts voted anonymously to select the top 10% of the 450 questions (which had been divided into 6 categories). And then 35 of the experts met at St. Catherine's to discuss, vote and rank the questions to provide a final list of 80 questions. The categories and the number of questions in each category are set out in Table 1.1.

It is clear from this exercise that ensuring future biological security was considered a complex task even before the pandemic struck in late 2019, and the pandemic has obviously made taking effective action to improve biological security for every nation much more urgent today.1

For this exercise, biological security was defined broadly to encompass the prevention of natural, accidental and deliberately caused diseases to humans, animals and plants. It suggested that:2

… Consistently emerging themes included: the nature of current and potential biological security threats, the efficacy of existing management actions, and the most appropriate future options …

Table 1.1 Topics and numbers of biosecurity questions.

Source: Adapted from reference 2.

Bioengineering technologies Questions 1–6

Communication and behavioural change Questions 7–17

Disease threats Questions 18–35

Governance and policy Questions 36–52

Invasive alien (non‐native) species Questions 53–67

Securing against misuse Questions 68–80

And the authors added that the resulting questions provided an ‘agenda for biological security’ in the future. They also noted that:

Many emerging biosecurity dilemmas, such as the malicious use of synthetic biology, require new approaches to biosecurity, including the engagement of social scientists and policy‐makers in forecasting …

In this book, we take a similarly broad science and social science approach, as we concentrate on the specific aspect of the potential deliberate disease in future biological security and the role that scientists can play in preventing the hostile misuse of their benignly intended work, but the much wider context of biological security must also be kept in mind.

Our understanding of deliberate biological threats has evolved rapidly in recent years. In the final decades of the last century, the threat was widely considered to be from biological warfare conducted by States, but early in this century, the rising concern about terrorism expanded that concern to include non‐State actors and sometimes indeed eclipsed the concerns about States. Then in the last two decades, concerns about experiments in the life and associated sciences that seemed to perhaps enable dangerous malicious activities by those with hostile intentions led to increasing concerns also about the direction and governance of the life and associated sciences. A concept that proved to be useful in considering how to deal with this expanded range of threats in a coherent manner started out as a ‘web of deterrence’ against State actions but has evolved into the idea of a ‘web of prevention’ linking a wide range of policies that together can help to minimise the possibility of the deliberate misuse of the life sciences.

As the authors of one study of this concept noted:3

… Biological threats are complex and multifaceted and hence, their effective prevention and countering require multiple lines of collaborative action and sustained cross‐sectorial coordination …

Therefore, they argued, actions required for biosafety and actions required for biosecurity, including the problem of the malign dual use of benignly intended work, should be integrated and seen as an:

… integrated and comprehensive web of prevention in which the efforts aimed at preventing the accidental release of biological agents or toxins, including naturally occurring disease and the efforts aimed to prevent the deliberate release of biological agents and toxins and the misuse of life sciences are complementary and reinforce each other … (Emphasis added)

We follow this reasoning here with biosafety, biosecurity both within the laboratory and outside of the laboratory being seen as complementary to other means of minimising the possibility of deliberate misuse of the life sciences such as export controls and codes of conduct for scientists, and regulatory measures seen as covering both pathogens and toxins (defined to include natural bioregulatory chemical agents such as neurotransmitters if used in unusual amounts or by unusual means).

As has been pointed out by many authors, one of the major difficulties anticipated for the future of assuring biosecurity is the very rapid rate of the advances being made in the life and associated sciences. The precise topics of concern will obviously vary given the different backgrounds and interests of various groups of authors, but this theme emerges strongly in all attempts to assess future developments over the next decades. For example, the World Health Organisation (WHO) published a horizon scan in 2021 titled Emerging technologies and dual‐use concerns: a horizon scan for global public health. This study was organised by the Science Division of the organisation and involved numerous outside experts. For the purpose of this study, dual‐use research of concern (DURC) was defined as:4

… life science research that is intended for benefit but which might be misapplied to do harm …

The study was organised to assess how such research that could have high impact might evolve over three time periods, up to 5 years, from 5 to 10 years and after 10 years. As in the UK study of biosecurity questions, the answers were derived from a systematic process involving topic identification, scoring, expert discussion and refinement and re‐scoring of the refined list. Table 1.2 shows the topics that were identified in the five‐year timescale.

Table 1.2 Priority DURC issues identified in the five‐year timescale.

Source: Adapted from reference 4.

Bioregulators

Cloud laboratories

De novo

synthesis of variola virus

Research on SARS‐Cov‐2

Synthetic genomics platforms for virus reconstruction

Now, most of these topics would not be of great surprise, few would dissent from the finding that:

… The expert group expected that there will be significant research into the determinants of the infectivity, severity and host specificity of SARS‐CoV‐2 within the next 5 years, as well as of immune evasion strategies …

However, it has to be stressed that the expert group saw potential dual‐use problems well beyond the frequent concentration on pathogens and genomics. In the five‐year timeframe, for example, it suggested that:

Bioregulators are biochemical compounds, such as peptides, that affect cellular processes. Research has identified a number of bioregulators and synthetic analogues that can modify life processes, including cognition, reproduction and development …. They can … be misused, and … have profound effects within minutes of exposure …

It should also be noted that in the longer beyond 10‐year period the ‘Hostile Exploitation of Neurobiology’ was identified as an additional field of dual‐use concern.

In 2022, the WHO published its up‐to‐date definitive Global guidance framework for the responsible use of the life sciences. This document was again the result of the work of numerous experts from diverse parts of the work that had been organised by the WHO, and it clearly identified the multiple stakeholders (Table 1.3) who can play a critical role in ensuring future biological security, and the many tools and mechanisms that are available to those stakeholders.

Important to note here is the clear identification of scientists and their institutions as having a key role to play in ensuring future biological security and that codes of ethics are one of the tools and mechanisms that can be utilised. As the guidance notes:5

… Codes of ethics can be a useful tool to raise awareness of the need for biorisk management and provide norm setting standards …. There have … been initiatives to outline high‐level principles that can serve as references in developing or amending codes of conduct …. The most recent is the Tianjin Biosecurity Guidelines for Codes of Conduct …

Table 1.3 Stakeholders identified by the WHO.

Source: Adapted from reference 5.

National governments

Scientists

Research institutions

Funding bodies

Publishers and editors

Standard‐setting institutions

Educators

International organisations

Civil society networks and publics

The private sector

However, the guidance stresses a major problem in its rationale for the global guidance framework stating that:

… A chronic and fundamental challenge is a widespread lack of awareness that work in this area – which is predominantly undertaken to advance knowledge and tools to improve health, economies and societies – could be conducted or misused in ways that result in health and society risks to the public. Also, incentives to identify and mitigate such risks are lacking.

Our objective in producing this book is to provide a one‐stop‐shop, where any interested scientist or other stakeholder can quickly grasp the main issues involved in dealing with the problem of dual use and ensuring biological security more generally. We additionally hope that it can easily be used by educators to add material about biological security to their teaching of life and associated science courses at multiple levels.

The difficulties in adding biosecurity to the education and culture of the life and associated scientist should not be under estimated in view of the vast numbers of such scientists around the world, the disparate nature of the fields within which they work and the rate of the advances being made in many of these fields of research. A further factor that needs to be taken into account is that scientists will increasingly have to take part in discussion with governments about how dual‐use dangers are to be regulated. An example of what may increasingly become matters of concern to scientists occurred in January 2023 when two Working Groups of the United States National Science Advisory Board for Biosecurity (NSABB) put forward new recommendations for the regulation of such experiments within the United States.6 The proposals related first to ‘Research with enhanced potential pandemic pathogens (ePPPs)’ and second to ‘Dual Use Research of Concern (DURC)’. The proposals were based on consideration of the efforts within the United States, particularly in the last decade, to minimise the dangers from particular types of experiments that could be of concern. The technical details of the recommendations need not be dealt with in this introduction and overview, except to note (Table 1.4) that should the proposals be accepted by government extra responsibilities will certainly fall upon practicing scientists.

Table 1.4 Some recommendations made by the NSABB.

Source: Adapted from reference 6.

Recommendation 3.1. Amend the US Government (USG) potential pandemic pathogen care and oversight (P3CO) framework to include and articulate specific roles, responsibilities and expectations for investigators and institutions in the identification, review and evaluation of research for potential involvement of ePPPs, taking into account existing review and oversight processes.

Recommendation 3.2. Local, institutional compliance procedures must be better harmonised, strengthened where needed and adequate technical and financial assistance provided.

Recommendation 8.2. Any updates to USG DURC policies, particularly updates regarding the scope of research subject to review and/or the relevant entities to which the policies apply, must involve relevant stakeholders and be accompanied by robust USG outreach and education and an adequate implementation period.

Table 1.5 The sections of the book.

Introduction and overview Chapter 1

The threat

Chapters 2

8

The international response

Chapters 9

12

The role of scientists

Chapters 13

18

The future

Chapters 19

20

It also seems most unlikely that other governments will not, in the not‐too‐distant future, also be moving along similar lines of requiring much more involvement of practicing life and associated scientists in the regulation of their benignly intended work.

1.2 The Structure of the Book

In order to meet our objective of providing a comprehensive, but also easy to use, source of information on biological security after the pandemic, we have divided the subject into 19 short chapters that are grouped into four sections following this introduction and overview section (Table 1.5). References have been kept to a small number but chosen so that they can provide a quick route into the more detailed literature for those who need or are interested in following up the issues discussed (however, some chapters have larger numbers of references, as the authors considered the material, they were covering, would be less familiar to readers than most of the book). The main sections of the WHO global guidance framework document, for example, have 154 references, and there are additional references in the annexes to the report.

The next part of this chapter briefly introduces the chapters and themes of the book.

1.3 Overview of the Chapters

Section 2 on the threat begins with an extended account, in Chapter 2 by Jean‐Pascal Zanders, of the way in which our understanding of poisons and infections has developed over the last 200 years as the sciences of first chemistry and then biology became established, and of how the international community has attempted to prevent the hostile use of these new sciences since the nineteenth century. Then in Chapter 3, Gemma Bowsher reviews how the many different actors with many different purposes have sought to use biological weapons in the past and also how the possible use of biological weapons is now being utilised in disinformation campaigns and infodemics. Brett Edwards describes the way in which the context and state of scientific knowledge influenced the potential to use biological weapons in antiquity through to 1946 (Chapter 4), and Brian Balmer reviews the offensive biological weapons programmes of States during the latter half of the twentieth century (Chapter 5). In Chapter 6, Kathryn Nixdorff investigates the developing concerns about dual‐use raised by a series of experiments in the early years of this century, and Xinyu Song and Weiwen Zang describe some of the key cutting‐edge technologies of concern today focusing particularly on synthetic biology and genome editing (Chapter 7). The section on the threat is rounded off by Chapter 8 in which Ralf Trapp discusses the convergence of other technologies, such as artificial intelligence (AI) and machine learning (ML) with biotechnology, that is causing increased concern about dual‐use applications.

Section 3 of the book begins with an account of the origin and development to date of the idea of the web of prevention by Tatyana Novossiolova in Chapter 9, and this is followed by a review of the structure and functions of the 1925 Geneva Protocol and the BTWC by Jez Littlewood (Chapter 10) and other relevant international agreements such as the Chemical Weapons Convention (CWC) by Michael Crowley (Chapter 11). The section ends with a review of the role of relevant international organisations such as the WHO and the International Committee of the Red Cross by Louison Mazeaud, James Revill, Jaroslav Krasny and Vivienne Zhang (Chapter 12).

Section 4 of the book turns to the key role that life and associated scientists can play in improving biosecurity and begins with a review of the elements of biorisk management by Mayra Ameneiros (Chapter 13), and this is followed by a description of two national regulatory systems one in the United States and the other in Georgia by Dana Perkins and Lela Bakanidze (Chapter 14). The lessons that can be derived from our recent experiences of ePPP research and the COVID‐19 pandemic are then investigated by Nariyoshi Shinomiya in Chapter 15. The Hague Ethical Guidelines and the Tianjin Biosecurity Guidelines are reviewed by Yang Xue (Chapter 16), and then the problem of engaging scientists in biorisk management is described by Yahan Bao and Alonso Flores in Chapter 17. Underpinning all the chapters lies the question of appropriate ethics and how this is to be applied, and this issue is discussed in the final Chapter 18 of the Section by Leifan Wang.

The book ends with two chapters in Section 5 which look towards the future. In Chapter 19, Nancy Connell and Gigi Gronwall examine the multi‐layered system of different components that are becoming interwoven in the efforts to effectively prevent the misuse of the life and associated sciences, and finally, in Chapter 20, Kathryn Millett and Lijun Shang stress the need for an IBSEN to be established quickly to support the effective biosecurity education of life and associate scientists in support of the Tianjin Biosecurity Guidelines.

Given the current shortage in resource books for teaching biosecurity, we hope that the book makes a useful contribution in helping to assist lecturers and teachers in universities and colleges to add elements of this subject to their courses, and we would like to particularly thank members of the faculty at Tianjin University who helped with the task of finalising the editing of this book.

Author Biography

Dr. Lijun Shang, BSc, MSc, PhD, FPhysoc., London Metropolitan University (LMU), United Kingdom. Lijun Shang is a professor of Biomedical Sciences at School of Human Sciences in London Metropolitan University (LMU). He is the founding director of Biological Security Research Centre at LMU. His research focuses mainly on ion channels in Health and Disease. Since 2015, he expanded his research interest into biochemical weapons and science convergence, as he wished to incorporate studies of the social impact of the advances in the life sciences. Since 2020, Professor Shang has been leading a series of projects in the effort to provide a civil society input into the broad Biological and Toxin Weapons Convention (BTWC).

Dr. Weiwen Zhang,